Automated next-generation profiling of genomic alterations in human cancers

The lack of validated, distributed comprehensive genomic profiling assays for patients with cancer inhibits access to precision oncology treatment. To address this, we describe elio tissue complete, which has been FDA-cleared for examination of 505 cancer-related genes. Independent analyses of clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Keefer, Laurel A., White, James R., Wood, Derrick E., Gerding, Kelly M. R., Valkenburg, Kenneth C., Riley, David, Gault, Christopher, Papp, Eniko, Vollmer, Christine M., Greer, Amy, Hernandez, James, McGregor, Paul M., Zingone, Adriana, Ryan, Bríd M., Deak, Kristen, McCall, Shannon J., Datto, Michael B., Prescott, James L., Thompson, John F., Cerqueira, Gustavo C., Jones, Siân, Simmons, John K., McElhinny, Abigail, Dickey, Jennifer, Angiuoli, Samuel V., Diaz, Luis A., Velculescu, Victor E., Sausen, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123004/
https://www.ncbi.nlm.nih.gov/pubmed/35595835
http://dx.doi.org/10.1038/s41467-022-30380-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123004/
https://www.ncbi.nlm.nih.gov/pubmed/35595835
http://dx.doi.org/10.1038/s41467-022-30380-x

Ejemplares similares